Acer Therapeutics Inc (NASDAQ:ACER)

3.95
Delayed Data
As of Dec 10
 +0.18 / +4.77%
Today’s Change
1.87
Today|||52-Week Range
28.25
-80.37%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$37.1M

Company Description

Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Edsivo and ACER-001. The Edsivo is a type of celiprolol for Vascular Ehlers-Danlos syndrome. The ACER-001 is for the treatment of urea cycle disorders and Maple Syrup Urine diseases. The company was founded by Christopher Schelling in September 2017 and is headquartered in Newton, MA.

Contact Information

Acer Therapeutics, Inc.
One Gateway Center
Newton Massachusetts 02458
P:(844) 902-6100
Investor Relations:

Employees

Shareholders

Mutual fund holders7.21%
Individual stakeholders45.38%
Other institutional19.03%

Top Executives

There are no executives to display.